teprotide has been researched along with Blood Pressure, High in 107 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 103 (96.26) | 18.7374 |
1990's | 2 (1.87) | 18.2507 |
2000's | 1 (0.93) | 29.6817 |
2010's | 1 (0.93) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Assakura, MT; Campeiro, JD; Hayashi, MA; Ianzer, D; Lopes, R; Neshich, G; Neshich, IP; Sant'Anna, OA | 1 |
Atlas, SA; Case, DB; Cody, RJ; Laragh, JH | 1 |
Hollenberg, NK; Williams, GH | 4 |
Brunner, HR; Gavras, H; Gavras, I | 1 |
Swales, JD | 1 |
Ogihara, T | 1 |
Dipalma, JR | 1 |
Burton, J; Cody, RJ; Haber, E; Herd, JA | 1 |
Case, DB; Laragh, JH; Niarchos, AP; Pickering, TG; Wallace, JM | 1 |
Limone, P; Molinatti, GM | 1 |
Brunner, H; Charocopos, F; Gavras, H; Gavras, I | 1 |
Atlas, SA; Case, DB; Laragh, JH; Sullivan, PA | 1 |
Jandhyala, B; Kjellstedt, A; Ljung, B | 1 |
Goldstein, DS | 1 |
Lee, MR | 1 |
Arbegast, PT; Blaine, EH; Gaul, SL; Gross, DM; Sweet, CS | 1 |
Iso, T; Iwao, J; Nakata, K; Nishimura, K; Suda, H; Yamauchi, H | 1 |
Cheung, HS; Cushman, DW; Ondetti, MA; Sabo, EF | 1 |
Hollenberg, NK | 3 |
Gross, F | 1 |
Feriozzi, S; Manzi, M; Santarossa, C | 1 |
Dimitrov, T | 2 |
Laragh, JH; Morganti, A; Niarchos, AP; Pickering, TG | 1 |
Jackson, B; Johnston, CI; Matthews, PG; McGrath, BP | 1 |
Amery, A; Fagard, R; Leuven, KU; Staessen, J | 1 |
Andrén, L; Dahlöf, B; Eggertsen, R; Gudbrandsson, T; Hansson, L; Jern, S; Sivertsson, R; Svensson, A | 1 |
Materson, BJ | 2 |
Haber, E | 1 |
Arnolda, L; Cubela, R; Jackson, B; Johnston, CI | 1 |
Bolli, P; Bühler, FR | 1 |
Cody, RJ | 1 |
Bauer, JH | 1 |
Bianchi, MD; Fernandes, M | 1 |
Brunner, HR; Gavras, H | 3 |
Kolloch, R; Overlack, A; Stumpe, KO | 1 |
Gordon, DB | 1 |
Laragh, JH | 2 |
Bing, J; Poulsen, K | 1 |
Case, DB; Drayer, JI; Keim, HJ; Laragh, JH; Sealey, JE; Wallace, JM; Weber, MA; White, RP | 1 |
Case, DB; Keim, HJ; Laragh, JH; Sealey, JE; Wallace, JM; Weber, MA | 1 |
Erdös, EG | 1 |
Case, DB; Keim, H; Laragh, JH; Wallace, JM | 1 |
Case, DB; Soffer, RL | 1 |
Case, DB; Drayer, JI; Keim, HJ; Laragh, JH; Sealey, JE; Wallace, JM | 1 |
Dluhy, RG; Hollenberg, NK; Moore, TJ; Swartz, SL; Williams, GH | 1 |
Brunner, HR; Gavras, H; Gavras, I; Rucinska, EJ; Textor, S; Volicer, L | 1 |
Prosnitz, EH | 1 |
Hollenberg, NK; Passan, DR; Swartz, SL; Williams, GH | 1 |
Arabidze, GG; Novikova, LS | 1 |
Case, DB; Laragh, JH; Wallace, JM | 1 |
Laragh, JH; Niarchos, AP; Roberts, AJ | 1 |
Atlas, SA; Drayer, JI; Laragh, JH; Weber, MA | 1 |
Cohn, JN; Levine, TB; Mashiro, I; Mehta, J | 1 |
Brunner, HR; Chobanian, AV; Gavras, H; Gavras, I; Kershaw, GR; Liang, CS; Tifft, CP | 1 |
Kolloch, RE; Krück, F; Redlich, B; Stumpe, KO; Vetter, H | 1 |
Dietz, R; Gross, F; Lüth, JB; Mann, JF | 1 |
Case, DB; Keim, HJ; Laragh, JH; Sealry, JE; Wallace, JM | 1 |
Bavli, SZ; Dluhy, RG; Hollenberg, NK; Mersey, JH; Moore, TJ; Solomon, HS; Williams, GH | 1 |
Adar, R; Jacob, ET; Kisin, E; Rosenthal, T; Rubinstein, Z; Stern, N | 1 |
Brunner, HR; Ferguson, RK; Gavras, H; Jaeger, P; Kirchertz, EJ | 1 |
Jennings, JC; Morrison, JC; Palmer, ET; Ratts, TE; Schoeneberger, AA; Sullivan, JM | 1 |
Krück, F; Overlack, A; Stumpe, KO | 1 |
Hökfelt, B; Hulthén, L | 1 |
Anderson, GH; Streeten, DH | 1 |
Swales, JD; Thurston, H | 1 |
Acchiardo, SR; Black, WD; Blackwell, CF; Friedman, BI; Hatch, FE; Johnson, JG; Muirhead, EE; Shade, RE; Share, L; Shenouda, AN; Vukovich, RA | 1 |
Brunner, HR; Gavras, H; Gavras, I; Laragh, JH; Vukovich, RA | 1 |
Brunner, H; Nussberger, J; Waeber, B | 1 |
Koppel, DM | 1 |
Robertson, JI | 1 |
Biollaz, J; Brunner, HR; Nussberger, J; Waeber, B | 1 |
Fouad, FM; Tarazi, RC | 1 |
Arnolda, L; Cubela, R; Jackson, B; Johnston, CI; Larmour, I | 1 |
Muiesan, G | 1 |
Ball, SG; Stott, DJ | 1 |
Tobian, L | 1 |
Brunner, HR; Nussberger, J; Waeber, B | 1 |
Blair, ML; Mangiapane, M; Sladek, CD | 1 |
Ferguson, RK; Riley, LJ; Vlasses, PH | 1 |
Higa, T; Kida, O; Kodama, K; Kondo, K; Morotomi, Y; Someya, N; Tanaka, K | 1 |
Anderson, S; Brenner, BM; Meyer, TW; Rennke, HG | 1 |
Stumpe, KO | 1 |
Dahlerup, J | 1 |
Jia, L | 1 |
Barres, C; Cerutti, C; Paultre, CZ; Sassard, J | 1 |
Thind, GS | 1 |
Koster, M | 1 |
Bauer, JH; Reams, GP | 1 |
Gavras, H; Gavras, I | 1 |
Irvin, JD; Viau, JM | 1 |
Takeda, T | 1 |
Fyhrquist, F | 1 |
McInnes, GT; Waller, PC | 1 |
Hodsman, GP; Johnston, CI | 1 |
Buckley, JP; Jandhyala, BS; Solomon, TA; Vollmer, R | 1 |
24 review(s) available for teprotide and Blood Pressure, High
Article | Year |
---|---|
Hypertension, the adrenal and the kidney: lessons from pharmacologic interruption of the renin-angiotensin system.
Topics: Adrenal Glands; Adrenergic beta-Antagonists; Aldosterone; Angiotensin II; Angiotensins; Animals; Blood Pressure; Disease Models, Animal; Humans; Hydrocortisone; Hypertension; Hypertension, Renal; Hypertension, Renovascular; Kidney; Renin; Saralasin; Teprotide | 1980 |
[The renin-angiotensin system. Physiopathological aspects and clinical implications of hypertensive syndromes. A survey].
Topics: Acromegaly; Aldosterone; Angiotensin I; Angiotensin II; Captopril; Cushing Syndrome; Glycoproteins; Humans; Hyperaldosteronism; Hypertension; Kidney; Kidney Diseases; Prostaglandins; Receptors, Adrenergic; Receptors, Angiotensin; Renin; Sodium; Sympathetic Nervous System; Teprotide | 1981 |
Present concepts and perspectives of antihypertensive therapy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Nifedipine; Oligopeptides; Serotonin Antagonists; Teprotide | 1982 |
[Role of renin-angiotensin system and its blockaders in the pathogenesis of arterial hypertension].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Hypertension; Renin; Renin-Angiotensin System; Teprotide | 1982 |
[Renin-angiotensin system blockers].
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensinogen; Animals; Humans; Hypertension; Kidney; Oligopeptides; Pepstatins; Renin; Renin-Angiotensin System; Teprotide | 1982 |
Angiotensin converting enzyme inhibitors in the treatment of hypertension.
Topics: Antihypertensive Agents; Captopril; Drug Eruptions; Dysgeusia; Humans; Hypertension; Hypotension; Neutropenia; Oligopeptides; Proteinuria; Teprotide | 1983 |
[Therapy of hypertensive heart disease: vasodilator agents in the forefront].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Heart Failure; Humans; Hypertension; Oligopeptides; Teprotide; Vasodilator Agents | 1984 |
Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Captopril; Dipeptides; Enalapril; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertension, Pulmonary; Kinetics; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Renin; Renin-Angiotensin System; Teprotide | 1984 |
Role of angiotensin converting enzyme inhibitors in essential and renal hypertension. Effects of captopril and enalapril on renin-angiotensin-aldosterone, renal function and hemodynamics, salt and water excretion, and body fluid composition.
Topics: Body Fluids; Captopril; Dipeptides; Drug Evaluation; Enalapril; Glomerular Filtration Rate; Hemodynamics; Humans; Hydrochlorothiazide; Hypertension; Hypertension, Renal; Potassium; Proline; Renin-Angiotensin System; Sodium; Teprotide | 1984 |
Monotherapy of hypertension with angiotensin-converting enzyme inhibitors.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Dipeptides; Enalapril; Heart Failure; Humans; Hypertension; Proline; Racial Groups; Teprotide; Time Factors | 1984 |
The kidney and strategies for the treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Nadolol; Natriuresis; Propanolamines; Propranolol; Renal Circulation; Renin-Angiotensin System; Teprotide; Vasodilator Agents | 1984 |
Role of angiotensin and its inhibition in hypertension, ischemic heart disease, and heart failure.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Coronary Circulation; Heart Failure; Hemodynamics; Humans; Hypertension; Male; Myocardial Ischemia; Renin; Renin-Angiotensin System; Saralasin; Teprotide | 2001 |
[Pharmacologic functional examination in arterial hypertension].
Topics: Adrenergic beta-Antagonists; Angiotensin II; Blood Pressure; Diagnosis, Differential; Diuretics; Ferricyanides; Furosemide; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Nitroprusside; Oligopeptides; Pheochromocytoma; Propranolol; Renal Veins; Renin; Saralasin; Stimulation, Chemical; Teprotide | 1977 |
The renin system in essential, renovascular and adrenocortical hypertension: an overview.
Topics: Aldosterone; Blood Volume; Female; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Hypertension, Renal; Middle Aged; Propranolol; Renal Veins; Renin; Saralasin; Sodium; Teprotide; Vasoconstriction | 1977 |
Converting enzyme, angiotensin II and hypertensive disease.
Topics: Amino Acid Sequence; Angiotensin II; Angiotensins; Animals; Antibodies; Blood Pressure; Chemistry; Fluorescent Antibody Technique; Goats; History, 19th Century; History, 20th Century; Humans; Hypertension; Kidney; Peptidyl-Dipeptidase A; Rabbits; Renin; Saralasin; Sodium; Teprotide | 1978 |
[Use of specific angiotensin inhibitors in the diagnosis and treatment of arterial hypertension].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Dogs; Humans; Hypertension; Hypertension, Renovascular; Infusions, Parenteral; Oligopeptides; Proline; Rabbits; Rats; Saralasin; Teprotide | 1979 |
Angiotensin as a renal, adrenal, and cardiovascular hormone: responses to saralasin in normal man and in essential and secondary hypertension.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Cardiovascular System; Diet; False Positive Reactions; Humans; Hypertension; Hypertension, Renal; Kidney; Posture; Rabbits; Receptors, Angiotensin; Renin; Saralasin; Sodium; Teprotide | 1979 |
Role of vasoconstrictor mechanisms in the control of left ventricular performance of the normal and damaged heart.
Topics: Animals; Captopril; Cardiography, Impedance; Dogs; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hypertension; Phenylephrine; Plethysmography, Impedance; Renin; Stroke Volume; Teprotide; Vasoconstriction | 1979 |
[Renin-angiotensin system blockade. What can be expected from angiotensin II antagonists?].
Topics: Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Humans; Hypertension; Imidazoles; Losartan; Renin-Angiotensin System; Teprotide; Tetrazoles | 1992 |
Rationale for the choice of antihypertensive agents.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Humans; Hypertension; Oligopeptides; Teprotide | 1986 |
Clinical pharmacology and therapeutic applications of the new oral converting enzyme inhibitor, enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Dipeptides; Enalapril; Heart Failure; Hemodynamics; Humans; Hyperaldosteronism; Hypertension; Kinetics; Oligopeptides; Renin; Teprotide | 1985 |
[Some advances in angiotensin converting enzyme inhibitors].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Heart Failure; Humans; Hypertension; Oligopeptides; Prostaglandins; Scleroderma, Systemic; Structure-Activity Relationship; Teprotide | 1985 |
Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Dizziness; Dose-Response Relationship, Drug; Enalapril; Half-Life; Headache; Humans; Hypertension; Kidney Diseases; Neutropenia; Oligopeptides; Skin Diseases; Sulfhydryl Compounds; Taste Disorders; Teprotide | 1986 |
Angiotensin converting enzyme inhibitors: drug interactions.
Topics: Diuretics; Drug Interactions; Humans; Hypertension; Oligopeptides; Teprotide; Vasodilator Agents | 1987 |
5 trial(s) available for teprotide and Blood Pressure, High
Article | Year |
---|---|
Monotherapy of hypertension with angiotensin-converting enzyme inhibitors.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Dipeptides; Enalapril; Heart Failure; Humans; Hypertension; Proline; Racial Groups; Teprotide; Time Factors | 1984 |
Phentolamine testing for alpha adrenergic participation in hypertensive patients: independence from from renin profiles.
Topics: Blood Pressure; Clinical Trials as Topic; Diet, Sodium-Restricted; Female; Heart Rate; Humans; Hypertension; Male; Phentolamine; Renin; Stimulation, Chemical; Teprotide | 1977 |
Chronic treatment of hypertensive patients with converting enzyme inhibitors.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cerebrovascular Circulation; Clinical Trials as Topic; Coronary Circulation; Enalapril; Heart Rate; Humans; Hypertension; Lipids; Oligopeptides; Peptidyl-Dipeptidase A; Potassium; Rats; Rats, Inbred SHR; Renin; Sodium; Teprotide | 1986 |
Clinical utility of angiotensin converting enzyme inhibitors in hypertension.
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Creatinine; Enalapril; Humans; Hypertension; Oligopeptides; Teprotide | 1986 |
Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Dizziness; Dose-Response Relationship, Drug; Enalapril; Half-Life; Headache; Humans; Hypertension; Kidney Diseases; Neutropenia; Oligopeptides; Skin Diseases; Sulfhydryl Compounds; Taste Disorders; Teprotide | 1986 |
80 other study(ies) available for teprotide and Blood Pressure, High
Article | Year |
---|---|
Identification of snake bradykinin-potentiating peptides (BPPs)-simile sequences in rat brain--Potential BPP-like precursor protein?
Topics: Amino Acid Sequence; Angiotensin-Converting Enzyme Inhibitors; Animals; Antibodies; Antihypertensive Agents; Blood Pressure; Bothrops; Escherichia coli; Gene Expression; Guinea Pigs; Heart Rate; Hypertension; Male; Mice; Models, Molecular; Molecular Sequence Data; Natriuretic Peptide, C-Type; Protein Precursors; Rats; Rats, Inbred SHR; Rats, Wistar; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Superoxide Dismutase; Teprotide | 2015 |
Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arterioles; Captopril; Enalapril; Enalaprilat; Heart Failure; Humans; Hypertension; Kinetics; Male; Nifedipine; Renin; Renin-Angiotensin System; Sodium; Teprotide; Vascular Resistance | 1983 |
Angiotensin inhibitors for hypertension.
Topics: Administration, Oral; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Humans; Hypertension; Injections, Intravenous; Oligopeptides; Proline; Renin; Sodium; Teprotide | 1980 |
Vascular renin in hypertension.
Topics: Animals; Aorta; Blood Pressure; Blood Vessels; Female; Humans; Hypertension; Hypertension, Renovascular; Kinetics; Nephrectomy; Rats; Renin; Sodium; Teprotide | 1980 |
[Clinical application of peptides with inhibition of renin-angiotensin system (author's transl)].
Topics: Adult; Angiotensin II; Female; Humans; Hypertension; Renin; Saralasin; Teprotide | 1980 |
Angiotensin-converting enzyme inhibitors.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Humans; Hypertension; Oligopeptides; Proline; Renin; Teprotide | 1980 |
Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Hypertension; Macaca fascicularis; Male; Oligopeptides; Peptidyl-Dipeptidase A; Renin; Sodium; Teprotide | 1980 |
Inhibitors of angiotensin I converting enzyme for treating hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diuretics; Humans; Hypertension; Renin; Teprotide | 1980 |
Hemodynamic effects of the converting enzyme inhibitor teprotide in normal- and high-renin hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Oligopeptides; Renin; Teprotide | 1980 |
Angiotensin converting enzyme inhibition: a new therapeutic modality.
Topics: Captopril; Heart Failure; Humans; Hypertension; Oligopeptides; Proline; Teprotide | 1981 |
Acute and chronic treatment of severe and malignant hypertension with the oral angiotensin-converting enzyme inhibitor captopril.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Blood Pressure; Captopril; Child; Chronic Disease; Diastole; Female; Heart Rate; Humans; Hypertension; Kidney Function Tests; Long-Term Care; Male; Middle Aged; Oligopeptides; Proline; Renin; Teprotide | 1981 |
Angiotensin I converting enzyme activity in portal vein studied in normotensive rats and in models of primary and secondary hypertension.
Topics: Angiotensin I; Angiotensin II; Angiotensins; Animals; Captopril; Hypertension; Male; Muscle, Smooth, Vascular; Oligopeptides; Portal Vein; Rats; Rats, Inbred Strains; Teprotide | 1981 |
Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiology.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Diazepam; Drug Interactions; Heart Failure; Heart Ventricles; Humans; Hypertension; Myocardial Infarction; Nitroprusside; Norepinephrine; Physical Exertion; Propranolol; Stress, Physiological; Sympathetic Nervous System; Teprotide; Ventricular Fibrillation | 1981 |
The renin/angiotensin system.
Topics: Angiotensin II; Angiotensins; Blood Pressure; Captopril; Humans; Hypertension; Ischemia; Kidney; Peptidyl-Dipeptidase A; Posture; Renin; Saralasin; Teprotide | 1981 |
Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
Topics: Angiotensin I; Angiotensins; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Dipeptides; Enalapril; Hypertension; Hypertension, Renal; Oligopeptides; Proline; Rats; Rats, Inbred Strains; Teprotide | 1981 |
A new potent inhibitor of converting enzyme: (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic acid(SA446).
Topics: 3-Mercaptopropionic Acid; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Guinea Pigs; Hypertension; Ileum; In Vitro Techniques; Male; Muscle Contraction; Oligopeptides; Sulfhydryl Compounds; Teprotide; Thiazolidines | 1981 |
Development and design of specific inhibitors of angiotensin-converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Humans; Hypertension; Peptidyl-Dipeptidase A; Proline; Renin-Angiotensin System; Succinates; Teprotide | 1982 |
Renal response to angiotensin-converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; Dogs; Glomerular Filtration Rate; Heart Failure; Humans; Hypertension; Kinins; Rabbits; Rats; Renal Circulation; Renin-Angiotensin System; Saralasin; Sodium; Teprotide; Water-Electrolyte Balance | 1982 |
[Essential hypertension: current therapeutic approach].
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Chronic Disease; Diet, Reducing; Diet, Sodium-Restricted; Diuretics; Enzyme Inhibitors; Humans; Hypertension; Middle Aged; Oligopeptides; Sympatholytics; Teprotide; Vasodilator Agents | 1982 |
Plasma catecholamines and cardiovascular responses during converting enzyme inhibition in normotensive and hypertensive man.
Topics: Adult; Blood Pressure; Captopril; Cardiac Output; Catecholamines; Hemodynamics; Humans; Hypertension; Middle Aged; Oligopeptides; Physical Exertion; Proline; Sodium; Teprotide | 1982 |
Treatment of hypertension with angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Hypertension; Hypertension, Renal; Oligopeptides; Renin; Renin-Angiotensin System; Teprotide | 1982 |
[Inhibition of the renin-angiotensin system in treating arterial hypertension].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Humans; Hypertension; Oligopeptides; Renin-Angiotensin System; Teprotide | 1982 |
[A review of recent pharmacological therapeutic principles in hypertension].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Calcium Channel Blockers; Central Nervous System Agents; Drug Combinations; Humans; Hypertension; Oligopeptides; Teprotide | 1983 |
Peptide inhibitors of renin in cardiovascular studies.
Topics: Amino Acid Sequence; Angiotensin I; Angiotensinogen; Animals; Blood Pressure; Enzyme Inhibitors; Heart Rate; Humans; Hypertension; Kinetics; Macaca fascicularis; Oligopeptides; Rats; Renin; Substrate Specificity; Swine; Teprotide | 1983 |
Mechanism for hypotensive action of angiotensin converting enzyme inhibitors.
Topics: Antihypertensive Agents; Blood Pressure; Dipeptides; Enalapril; Enalaprilat; Enzyme Induction; Humans; Hypertension; Oligopeptides; Peptidyl-Dipeptidase A; Teprotide | 1984 |
Converting-enzyme inhibition and glomerular filtration rate in essential hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Glomerular Filtration Rate; Humans; Hypertension; Oligopeptides; Teprotide | 1980 |
Editorial: Mechanisms in hypertension.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Oligopeptides; Rats; Renin; Saralasin; Teprotide | 1975 |
Renin lowers blood-pressure.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Kallikreins; Kidney; Mice; Rats; Renin; Saralasin; Teprotide; Vasodilator Agents | 1978 |
Time course of changes in plasma renin after blockade of the renin-system. Studies of conscious and anaesthetized, normal, adrenalectomized and spontaneously hypertensive rats.
Topics: Adrenalectomy; Anesthesia; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Depression, Chemical; Desoxycorticosterone; Female; Hydralazine; Hypertension; Juxtaglomerular Apparatus; Oligopeptides; Rats; Renin; Saralasin; Sodium Chloride; Stimulation, Chemical; Teprotide; Time Factors | 1975 |
Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
Topics: Adolescent; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Female; Humans; Hypertension; Hypertension, Renal; Kidney Diseases; Male; Middle Aged; Oligopeptides; Renin; Saralasin; Sodium; Teprotide | 1976 |
Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Depression, Chemical; Humans; Hypertension; Oligopeptides; Posture; Renin; Sodium; Teprotide | 1977 |
The angiotensin I converting enzyme.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antigen-Antibody Reactions; Blood Vessels; Bradykinin; Glycoproteins; Humans; Hypertension; Kidney; Lung; Molecular Weight; Peptidyl-Dipeptidase A; Shock, Hemorrhagic; Species Specificity; Sulfhydryl Reagents; Teprotide | 1977 |
Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Volume; Humans; Hypertension; Models, Biological; Natriuresis; Oligopeptides; Propranolol; Renin; Saralasin; Teprotide; Vascular Resistance | 1977 |
Accentuated vascular and endocrine response to SQ 20881 in hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Bradykinin; Humans; Hypertension; Kidney; Oligopeptides; Regional Blood Flow; Renin; Teprotide | 1977 |
The immediate pressor response to saralasin: a measure of the degree of angiotensin II vascular receptor vacancy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Humans; Hypertension; Kinetics; Receptors, Angiotensin; Receptors, Cell Surface; Renin; Saralasin; Teprotide | 1977 |
The adrenal receptor for angiotensin II is altered in essential hypertension.
Topics: Adrenal Glands; Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Humans; Hypertension; Hypertension, Renovascular; Middle Aged; Receptors, Angiotensin; Receptors, Cell Surface; Saralasin; Teprotide | 1979 |
Effect of angiotensin converting enzyme inhibition on blood pressure, plasma renin activity and plasma aldosterone in essential hypertension.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Oligopeptides; Posture; Renin; Sodium; Teprotide | 1978 |
Enzyme inhibitor therapy of hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Enzyme Inhibitors; Humans; Hypertension; Proline; Saralasin; Teprotide | 1979 |
Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Glomerular Filtration Rate; Humans; Hypertension; Hypertension, Renovascular; Kidney; Oligopeptides; Renal Artery Obstruction; Renin; Sodium; Teprotide; Vasoconstriction | 1979 |
Comparison between saralsin and converting enzyme inhibitor in hypertensive disease.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Humans; Hypertension; Hypertension, Renovascular; Oligopeptides; Renin; Saralasin; Sodium; Teprotide | 1979 |
Effects of the converting enzyme inhibitor (SQ 20881) on the pulmonary circulation in man.
Topics: Adult; Blood Pressure; Cardiac Output; Coronary Artery Bypass; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Oligopeptides; Postoperative Complications; Pulmonary Artery; Pulmonary Circulation; Renin; Teprotide; Vascular Resistance | 1979 |
Converting enzyme inhibition in hypertensive emergencies.
Topics: Adult; Emergencies; Female; Humans; Hypertension; Male; Middle Aged; Oligopeptides; Propranolol; Renin; Teprotide; Vasodilator Agents | 1979 |
[Diagnostic and therapeutic significance of inhibitors of the renin-angiotensin system].
Topics: Angiotensin II; Animals; Dogs; Humans; Hypertension; Kinins; Oligopeptides; Pindolol; Propranolol; Renin; Saralasin; Teprotide | 1977 |
[What role does the renin-angiotensin system have in the pathogenesis of hypertension?].
Topics: Aldosterone; Angiotensin II; Animals; Corticosterone; Desoxycorticosterone; Extracellular Space; Hypertension; Hypertension, Renal; Hyponatremia; Rats; Renal Artery Obstruction; Renin; Saralasin; Sodium; Sodium Chloride; Teprotide | 1977 |
[Angiotensin blockade in the diagnosis of hypertension].
Topics: Angiotensin II; Blood Pressure; Humans; Hypertension; Oligopeptides; Renin; Saralasin; Sodium; Teprotide | 1977 |
Failure of renin suppression by angiotensin II in hypertension.
Topics: Adult; Angiotensin II; Blood Pressure; Depression, Chemical; Diet, Sodium-Restricted; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Hypertension, Renal; Male; Renin; Teprotide; Time Factors | 1978 |
Use of the angiotensin I antagonist, SQ 20881, for lateralizing renal venous renin activity.
Topics: Adolescent; Adult; Aldosterone; Angiotensin I; Angiotensins; Blood; Blood Pressure; Humans; Hypertension; Male; Middle Aged; Oligopeptides; Renal Veins; Renin; Teprotide | 1978 |
Mechanism of blood pressure reduction by teprotide (SQ 20881) in rats.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Depression, Chemical; Drug Interactions; Female; Hypertension; Nephrectomy; Oligopeptides; Rats; Saralasin; Sodium Chloride; Teprotide | 1978 |
SQ 20,881: effect on eclamptic--pre-eclamptic women with postpartum hypertension.
Topics: Adolescent; Adult; Angiotensin II; Eclampsia; Female; Furosemide; Hemodynamics; Humans; Hypertension; Oligopeptides; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, Third; Puerperal Disorders; Renin; Teprotide | 1978 |
[Diagnostic and therapeutic significance of antagonists of the renin-angiotensin system (author's transl)].
Topics: Angiotensin II; Animals; Blood Pressure; Dogs; Humans; Hypertension; Oligopeptides; Propranolol; Saralasin; Teprotide | 1978 |
The effect of the converting enzyme inhibitor SQ 20.881 on kinins, renin-angiotensin-aldosterone and catecholamines in relation to blood pressure in hypertensive patients.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Catecholamines; Epinephrine; Female; Humans; Hypertension; Kinins; Male; Middle Aged; Norepinephrine; Oligopeptides; Posture; Renin; Teprotide | 1978 |
Angiotensin blockade in hypertension.
Topics: Angiotensin II; Hypertension; Posture; Renin; Saralasin; Sodium; Teprotide | 1977 |
Blood pressure response of nephrectomized hypertensive rats to converting enzyme inhibition: evidence for persistent vascular renin activity.
Topics: Angiotensin II; Animals; Arteries; Blood Pressure; Female; Hypertension; Ischemia; Kidney; Nephrectomy; Oligopeptides; Rats; Renin; Saralasin; Teprotide | 1977 |
[Angiotensin II inhibitors for the diagnosis and treatment of hypertension].
Topics: Adult; Angiotensin II; Animals; Humans; Hypertension; Hypertension, Renal; Male; Oligopeptides; Rats; Renin; Saralasin; Sodium; Teprotide | 1976 |
Treatment of patients with severe hypertension by inhibition of angiotensin-converting enzyme.
Topics: Blood Pressure; Blood Volume; Dose-Response Relationship, Drug; Furosemide; Humans; Hypertension; Oligopeptides; Renin; Sodium; Teprotide; Time Factors | 1975 |
The use of angiotensin-converting enzyme inhibitor in the diagnosis and treatment of hypertension.
Topics: Adolescent; Adult; Aldosterone; Blood Pressure; Diet, Sodium-Restricted; Drug Evaluation; Female; Humans; Hypertension; Male; Middle Aged; Oligopeptides; Renin; Teprotide; Time Factors | 1975 |
Clinical implications of renin in the hypertensive patient.
Topics: Angiotensin II; Blood Pressure; Blood Volume; Humans; Hyperaldosteronism; Hypertension; Renin; Saralasin; Sodium; Teprotide | 1975 |
Clarification of vasotec and teprotide dosages.
Topics: Enalaprilat; Humans; Hypertension; Injections, Intravenous; Teprotide | 1991 |
Circulatory basis for the use of angiotensin converting enzyme inhibitors in hypertension and cardiac failure.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Benzothiadiazines; Blood Pressure; Diuretics; Dogs; Enalapril; Enzyme Inhibitors; Heart Failure; Humans; Hypertension; Hypertension, Renovascular; Kidney; Oligopeptides; Rats; Renal Circulation; Renin-Angiotensin System; Sodium Chloride Symporter Inhibitors; Teprotide | 1986 |
Restoration of cardiac function and structure by converting enzyme inhibition possibilities and limitations of long-term treatment in hypertension and heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomegaly; Coronary Circulation; Enalapril; Heart; Heart Failure; Heart Ventricles; Humans; Hypertension; Oligopeptides; Rats; Teprotide | 1986 |
Evaluation of angiotensin converting enzyme (ACE) in the pharmacokinetics and pharmacodynamics of ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Biological Availability; Enalapril; Enalaprilat; Enzyme Inhibitors; Esterification; Humans; Hypertension; Kinetics; Liver; Oligopeptides; Peptidyl-Dipeptidase A; Teprotide | 1986 |
Treatment of essential hypertension.
Topics: Adrenergic beta-Agonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Calcium Channel Blockers; Combined Modality Therapy; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Middle Aged; Oligopeptides; Sodium Chloride Symporter Inhibitors; Teprotide | 1986 |
Perspectives on treating hypertension.
Topics: Adrenergic beta-Antagonists; Animals; Benzothiadiazines; Biological Evolution; Blood Pressure; Cerebrovascular Disorders; Diet, Sodium-Restricted; Disease Susceptibility; Diuretics; Humans; Hypertension; Middle Aged; Natriuretic Agents; Oligopeptides; Potassium; Rats; Sodium; Sodium Chloride Symporter Inhibitors; Teprotide | 1986 |
[Therapeutic strategy in arterial hypertension].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hypertension; Oligopeptides; Teprotide | 1987 |
Evidence against a pressor role for vasopressin in spontaneous hypertension.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Hypertension; Male; Rats; Rats, Inbred SHR; Receptors, Angiotensin; Receptors, Vasopressin; Renin-Angiotensin System; Teprotide; Vasopressins | 1987 |
Effects of angiotensin converting enzyme inhibitor and angiotensin II analogue on hypertension. Study of hypertension with two different blockers of the renin-angiotensin-aldosterone system.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Humans; Hypertension; Male; Middle Aged; Oligopeptides; Renin-Angiotensin System; Teprotide | 1985 |
Advances in therapeutics: converting enzyme inhibition and the kidney.
Topics: Humans; Hypertension; Hypertension, Renal; Kidney; Oligopeptides; Renin-Angiotensin System; Sodium; Teprotide | 1985 |
Are non-modulating patients with essential hypertension a distinct subgroup? Implications for therapy.
Topics: Adrenal Glands; Adult; Aldosterone; Angiotensin II; Female; Furosemide; Humans; Hypertension; Kidney; Male; Middle Aged; Natriuresis; Oligopeptides; Renal Circulation; Sodium; Teprotide | 1985 |
Converting enzyme inhibitor therapy limits progressive glomerular injury in rats with renal insufficiency.
Topics: Animals; Enalapril; Glomerulosclerosis, Focal Segmental; Hypertension; Kidney Failure, Chronic; Kidney Glomerulus; Male; Oligopeptides; Proteinuria; Rats; Rats, Inbred Strains; Teprotide | 1985 |
[Angiotensin-converting enzyme inhibition: direct and indirect mechanisms].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Feedback; Glomerular Filtration Rate; Humans; Hypertension; Hypertension, Renovascular; Kinins; Rats; Rats, Inbred SHR; Renal Circulation; Renin-Angiotensin System; Sodium; Stroke Volume; Teprotide; Vascular Resistance; Water-Electrolyte Balance | 1985 |
[Drug information. New principle in the treatment of elevated blood pressure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Enzyme Inhibitors; Humans; Hypertension; Oligopeptides; Teprotide | 1985 |
Antihypertensive effects of S9490-3, a new converting enzyme inhibitor, in the conscious spontaneously hypertensive rat.
Topics: Administration, Oral; Animals; Blood Pressure; Drug Administration Schedule; Heart Rate; Hypertension; Indoles; Injections, Intravenous; Male; Oligopeptides; Perindopril; Rats; Rats, Inbred SHR; Teprotide | 1986 |
Renal insufficiency during angiotensin-converting enzyme inhibitor therapy in hypertensive patients with no renal artery stenosis.
Topics: Acute Kidney Injury; Captopril; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Hypertension, Renovascular; Kidney Diseases; Male; Middle Aged; Oligopeptides; Teprotide | 1985 |
[Calcium channel blockers and angiotensin converting enzyme inhibitors in the treatment of high blood pressure].
Topics: Calcium Channel Blockers; Captopril; Drug Interactions; Enalapril; Humans; Hypertension; Nifedipine; Oligopeptides; Teprotide; Verapamil | 1986 |
Renal effects of angiotensin converting enzyme inhibitors in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Body Fluids; Captopril; Enalapril; Glomerular Filtration Rate; Humans; Hypertension; Hypertension, Renal; Kidney; Oligopeptides; Proteinuria; Regional Blood Flow; Renin-Angiotensin System; Sodium Chloride; Teprotide | 1986 |
[Treatment of circulatory diseases: recent progress. 1. Hypertension].
Topics: Calcium Channel Blockers; Diuretics, Osmotic; Humans; Hypertension; Oligopeptides; Sympathomimetics; Teprotide | 1986 |
[The clinical use of angiotensin converting enzyme inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Enzyme Inhibitors; Humans; Hypertension; Oligopeptides; Teprotide | 1986 |
Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Diet; Humans; Hypertension; Oligopeptides; Sodium; Teprotide | 1987 |
A new look at the hypertension problem: the role of the renin system for analysis and treatment.
Topics: Angiotensin II; Arginine Vasopressin; Blood Pressure; Calcium; Captopril; Cold Temperature; Enzyme Precursors; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Hypertension, Renal; Magnesium; Natriuretic Agents; Propranolol; Renin; Renin-Angiotensin System; Saralasin; Sodium; Teprotide | 1985 |
Central hypertensive actions of angiotensin.
Topics: Angiotensin II; Animals; Blood Pressure; Cats; Cerebral Ventricles; Drug Synergism; Hypertension; Injections, Intraventricular; Oligopeptides; Phentolamine; Saralasin; Stimulation, Chemical; Teprotide | 1974 |